Successful DNA immunization against measles

Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles

Fernando P. Polack, Sok H. Lee, Sallie Permar, Elizabeth Manyara, Hossein G. Nousari, Yaikah Jeng, Farah Mustafa, Alexandra Valsamakis, Robert John Adams, Harriet L. Robinson, Diane Griffin

Research output: Contribution to journalArticle

Abstract

Measles remains a principal cause of worldwide mortality, in part because young infants cannot be immunized effectively. Development of new vaccines has been hindered by previous experience with a formalin-inactivated vaccine that predisposed to a severe form of disease (atypical measles). Here we have developed and tested potential DNA vaccines for immunogenicity, efficacy and safety in a rhesus macaque model of measles. DNA protected from challenge with wild-type measles virus. Protection correlated with levels of neutralizing antibody and not with cytotoxic T lymphocyte activity. There was no evidence in any group, including those receiving hemagglutinin-encoding DNA alone, of 'priming' for atypical measles.

Original languageEnglish (US)
Pages (from-to)776-781
Number of pages6
JournalNature Medicine
Volume6
Issue number7
DOIs
StatePublished - Jul 2000

Fingerprint

Immunization
Measles
Hemagglutinins
Neutralizing Antibodies
Macaca mulatta
Glycoproteins
Fusion reactions
Inactivated Vaccines
DNA Vaccines
T-cells
DNA
Viruses
Formaldehyde
Vaccines
Measles virus
Cytotoxic T-Lymphocytes
Safety
Mortality

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Successful DNA immunization against measles : Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. / Polack, Fernando P.; Lee, Sok H.; Permar, Sallie; Manyara, Elizabeth; Nousari, Hossein G.; Jeng, Yaikah; Mustafa, Farah; Valsamakis, Alexandra; Adams, Robert John; Robinson, Harriet L.; Griffin, Diane.

In: Nature Medicine, Vol. 6, No. 7, 07.2000, p. 776-781.

Research output: Contribution to journalArticle

Polack, Fernando P. ; Lee, Sok H. ; Permar, Sallie ; Manyara, Elizabeth ; Nousari, Hossein G. ; Jeng, Yaikah ; Mustafa, Farah ; Valsamakis, Alexandra ; Adams, Robert John ; Robinson, Harriet L. ; Griffin, Diane. / Successful DNA immunization against measles : Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. In: Nature Medicine. 2000 ; Vol. 6, No. 7. pp. 776-781.
@article{67492a9cb4d14d5094e0dfafba8274d7,
title = "Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles",
abstract = "Measles remains a principal cause of worldwide mortality, in part because young infants cannot be immunized effectively. Development of new vaccines has been hindered by previous experience with a formalin-inactivated vaccine that predisposed to a severe form of disease (atypical measles). Here we have developed and tested potential DNA vaccines for immunogenicity, efficacy and safety in a rhesus macaque model of measles. DNA protected from challenge with wild-type measles virus. Protection correlated with levels of neutralizing antibody and not with cytotoxic T lymphocyte activity. There was no evidence in any group, including those receiving hemagglutinin-encoding DNA alone, of 'priming' for atypical measles.",
author = "Polack, {Fernando P.} and Lee, {Sok H.} and Sallie Permar and Elizabeth Manyara and Nousari, {Hossein G.} and Yaikah Jeng and Farah Mustafa and Alexandra Valsamakis and Adams, {Robert John} and Robinson, {Harriet L.} and Diane Griffin",
year = "2000",
month = "7",
doi = "10.1038/77506",
language = "English (US)",
volume = "6",
pages = "776--781",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Successful DNA immunization against measles

T2 - Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles

AU - Polack, Fernando P.

AU - Lee, Sok H.

AU - Permar, Sallie

AU - Manyara, Elizabeth

AU - Nousari, Hossein G.

AU - Jeng, Yaikah

AU - Mustafa, Farah

AU - Valsamakis, Alexandra

AU - Adams, Robert John

AU - Robinson, Harriet L.

AU - Griffin, Diane

PY - 2000/7

Y1 - 2000/7

N2 - Measles remains a principal cause of worldwide mortality, in part because young infants cannot be immunized effectively. Development of new vaccines has been hindered by previous experience with a formalin-inactivated vaccine that predisposed to a severe form of disease (atypical measles). Here we have developed and tested potential DNA vaccines for immunogenicity, efficacy and safety in a rhesus macaque model of measles. DNA protected from challenge with wild-type measles virus. Protection correlated with levels of neutralizing antibody and not with cytotoxic T lymphocyte activity. There was no evidence in any group, including those receiving hemagglutinin-encoding DNA alone, of 'priming' for atypical measles.

AB - Measles remains a principal cause of worldwide mortality, in part because young infants cannot be immunized effectively. Development of new vaccines has been hindered by previous experience with a formalin-inactivated vaccine that predisposed to a severe form of disease (atypical measles). Here we have developed and tested potential DNA vaccines for immunogenicity, efficacy and safety in a rhesus macaque model of measles. DNA protected from challenge with wild-type measles virus. Protection correlated with levels of neutralizing antibody and not with cytotoxic T lymphocyte activity. There was no evidence in any group, including those receiving hemagglutinin-encoding DNA alone, of 'priming' for atypical measles.

UR - http://www.scopus.com/inward/record.url?scp=0033940560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033940560&partnerID=8YFLogxK

U2 - 10.1038/77506

DO - 10.1038/77506

M3 - Article

VL - 6

SP - 776

EP - 781

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 7

ER -